483 Takeda Pharmaceutical Company Sep 2015

483 Takeda Pharmaceutical Company Sep 2015

Scott Ballard FDA, Susanne Richardson FDA$119.00 - Available Now

FDA investigators audited the Takeda Pharmaceutical Company - Osaka, Japan facility and issued 2 inspectional observations (via FDA 483) on 18 Sep 2015.

Product details

  • Category: Human Drugs
  • Number of Observations: 2
  • Inspection end: 18 Sep 2015
  • Location: Osaka, Japan
  • FEI: 3002808311
Add To Cart